Riskpilot← Back to searchSign inGet full accessNytorgstandläkarna AB
ABActiveOrg 5568320906Tegelviksgatan 45 Lgh 1201Dental practice care activities · NACE 8623Est. 20105-9 employees
Revenue 2024
SEK 6,3M
+17% vs 2023
EBITDA margin
5.0%
-49% vs 2023
Equity ratio
28.3%
Financial strength
Net profit 2024
SEK 64K
-80% vs 2023
| Revenue | SEK 6,3M | +17% |
| EBITDA | SEK 317K | -49% |
| Net profit | SEK 64K | -80% |
| Total assets | SEK 4M | -11% |
| Equity | SEK 1,1M | -8% |
| Employees | — | — |
Legal name
Nytorgstandläkarna AB
Org number
5568320906
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
14 december 2010
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Tandvård som bedrivs av tandläkare samt tandhygienist Skönhetsvård, Injektionsbehandling sam Tandblekning Försäljning av tandsvårdsmaterial samt skönhetsartiklar uthyrning av rum på kliniken för bedrivande av tandvård och sjukvårdkonsultverksamt inom tandvård import av dentalartiklar utbildningsverksamhet för tandvård
Address
Tegelviksgatan 45 Lgh 1201
Phone
+46764375559
Email
info@nytand.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 528 | 4 925 | 4 695 | 5 354 | 6 286 |
| Staff expenses | — | — | −1 899 | −1 947 | −2 028 |
| EBITDA | 964 | 461 | 56 | 624 | 317 |
| Depreciation & amort. | −267 | −109 | −115 | −110 | −105 |
| EBIT | 697 | 352 | −59 | 514 | 213 |
| Net financials | −114 | −105 | −87 | −125 | −126 |
| Profit before tax | 583 | 246 | −146 | 389 | 87 |
| Tax | −64 | −58 | — | −63 | −23 |
| Net profit | 519 | 188 | −146 | 326 | 64 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 035 | 4 520 | 4 097 | 4 505 | 4 022 |
| Equity | 868 | 1 056 | 911 | 1 236 | 1 140 |
| Long-term debt | 3 849 | 2 770 | 2 770 | 2 857 | 2 531 |
| Short-term debt | 318 | 693 | 416 | 412 | 351 |
| Total debt | 4 167 | 3 463 | 3 186 | 3 269 | 2 882 |
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
20202024
Equity ratio
28.3%
This company
38.2%
Market median
-26% vs market
20202024
Return on equity
5.6%
This company
18.4%
Market median
-70% vs market
20202024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20202024
Asset turnover
1.56×
This company
1.12×
Market median
+39% vs market
20202024
Debt / equity
2.53×
This company
0.62×
Market median
-308% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
YM | Audit | 2024 |
SM Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
ZV Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nytorgstandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ylva Marie Ekmark Tjärnberg | Audit | 0 companies |
| Zinovea Vavolidu | Audit | 0 companies |
| Sara Matak | Chief Executive Officer | 0 companies |
| Masoud Mohammadi Matak | Deputy Board Member | 0 companies |